Inhibitors of Protein Convertase Subtilisin/Kexin 9 (PCSK9) and Acute Coronary Syndrome (ACS): The State-of-the-Art
出版年份 2021 全文链接
标题
Inhibitors of Protein Convertase Subtilisin/Kexin 9 (PCSK9) and Acute Coronary Syndrome (ACS): The State-of-the-Art
作者
关键词
-
出版物
Journal of Clinical Medicine
Volume 10, Issue 7, Pages 1510
出版商
MDPI AG
发表日期
2021-04-05
DOI
10.3390/jcm10071510
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Changes in carotid stiffness in patients with familial hypercholesterolemia treated with Evolocumab®: A prospective cohort study
- (2020) Matteo Nicola Dario Di Minno et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
- (2020) Kausik K. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Evolocumab on Atherogenic Lipoproteins During the Peri- and Early Postinfarction Period
- (2020) Thorsten M. Leucker et al. CIRCULATION
- PCSK9 Enhances Platelet Activation, Thrombosis, and Myocardial Infarct Expansion by Binding to Platelet CD36
- (2020) Zhiyong Qi et al. CIRCULATION
- Endothelial function improvement in patients with familial hypercholesterolemia receiving PCSK-9 inhibitors on top of maximally tolerated lipid lowering therapy
- (2020) Alessandro Di Minno et al. THROMBOSIS RESEARCH
- Association between atherogenic index of plasma and carotid intima-media thickness in a cohort of Mediterranean women
- (2020) M. Gentile et al. ACTA CARDIOLOGICA
- Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
- (2020) Gregory A. Roth et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lipoprotein(a), PCSK9 Inhibition and Cardiovascular Risk: Insights from the FOURIER Trial
- (2019) Michelle L. O'Donoghue et al. CIRCULATION
- CD36 signaling in vascular redox stress
- (2019) Moua Yang et al. FREE RADICAL BIOLOGY AND MEDICINE
- Cardiovascular events and death after myocardial infarction or ischemic stroke in an older Medicare population
- (2019) Suying Li et al. CLINICAL CARDIOLOGY
- One-Year Outcomes of Patients With Established Coronary Artery Disease Presenting With Acute Coronary Syndromes
- (2019) Alexandra Murphy et al. AMERICAN JOURNAL OF CARDIOLOGY
- Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials
- (2019) Paul Guedeney et al. EUROPEAN HEART JOURNAL
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- Evolocumab for Early Reduction of LDL-Cholesterol Levels in Patients with Acute Coronary Syndromes (EVOPACS)
- (2019) Konstantinos C. Koskinas et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- PCSK9 and inflammation: role of shear stress, pro-inflammatory cytokines, and LOX-1
- (2019) Zufeng Ding et al. CARDIOVASCULAR RESEARCH
- Lipoprotein (a) is an independent predictor of cardiovascular events in Mediterranean women (Progetto Atena)
- (2019) Marco Gentile et al. European Journal of Preventive Cardiology
- Diagnosing Resistance to a Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor
- (2018) Michael D. Shapiro et al. ANNALS OF INTERNAL MEDICINE
- Lipid management in ACS: Should we go lower faster?
- (2018) Gencer Baris et al. ATHEROSCLEROSIS
- Assessment of the 1% of Patients with Consistent
- (2018) Harold E. Bays et al. CARDIOVASCULAR DRUGS AND THERAPY
- PCSK9
- (2018) Michael D. Shapiro et al. CIRCULATION RESEARCH
- The Evolving Future of PCSK9 Inhibitors
- (2018) Robert S. Rosenson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
- (2018) Scott M. Grundy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
- (2018) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interindividual Variation in Low-Density Lipoprotein Cholesterol Level Reduction With Evolocumab
- (2018) Arman Qamar et al. JAMA Cardiology
- Association of PCSK9 with platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor: The PCSK9-REACT study
- (2017) Eliano P. Navarese et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Exploration of PCSK9 as a Cardiovascular Risk Factor
- (2017) Paul A. Gurbel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Relationship of PCSK9 and Urinary Thromboxane Excretion to Cardiovascular Events in Patients With Atrial Fibrillation
- (2017) Daniele Pastori et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol
- (2017) Kausik K. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Proprotein Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies for Acute Coronary Syndrome
- (2016) Eliano P. Navarese et al. ANNALS OF INTERNAL MEDICINE
- Biology of proprotein convertase subtilisin kexin 9: beyond low-density lipoprotein cholesterol lowering
- (2016) Giuseppe Danilo Norata et al. CARDIOVASCULAR RESEARCH
- Residual Ischemic Risk and Its Determinants in Patients With Previous Myocardial Infarction and Without Prior Stroke or TIA: Insights From the REACH Registry
- (2016) Jérémie Abtan et al. CLINICAL CARDIOLOGY
- Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions
- (2016) Michael G. Silverman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Hemodynamic Shear Stress via ROS Modulates PCSK9 Expression in Human Vascular Endothelial and Smooth Muscle Cells and Along the Mouse Aorta
- (2015) Zufeng Ding et al. ANTIOXIDANTS & REDOX SIGNALING
- Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
- (2015) Erik S. Stroes et al. EUROPEAN HEART JOURNAL
- Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective
- (2015) Tomas Jernberg et al. EUROPEAN HEART JOURNAL
- Ezetimibe plus a Statin after Acute Coronary Syndromes
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia-Full report
- (2013) Scott M. Grundy et al. Journal of Clinical Lipidology
- Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol
- (2012) Evan A. Stein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Circulating Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Regulates VLDLR Protein and Triglyceride Accumulation in Visceral Adipose Tissue
- (2011) Anna Roubtsova et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality
- (2009) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now